Corporate Governance. Opexa Therapeutics (NASDAQ:OPXA) is a biotechnology company dedicated to the development of patient-specific cellular therapies for the ...
Investor Relations · Why Invest · Press Releases ... Quick Links. Financial Reports · FAQs · Contact IR · About ... 281.872.8585. © 2017 Opexa Therapeutics, Inc.
Missing: opxa | Show results with:opxa
May 24, 2013 · Investor Relations. News Release Details ... [OPXA] to Ring The NASDAQ Stock Market Closing Bell ... [OPXA]:. Opexa's mission is to lead the field ...
Investor Relations. Cases. Currently there are no cases. Investigations. Title, Updated, Security. Opexa Therapeutics Inc (NASDAQ:OPXA) Investor Investigation ...
Jul 3, 2017 · In conjunction with the proposed merger, an investor syndicate led by TVM Capital Life Sciences and comprised of existing Acer investors and new ...
Oct 2, 2014 · Opexa Therapeutics today announced that it will hold an Analyst and Investor Event in New York City, New York on Thursday, October 9, 2014.
Sep 1, 2015 · Opexa Therapeutics (OPXA) enters into a stock purchase agreement with a private investor - BUY ... To fund its NMO program, including its planned ...
Jul 3, 2017 · (Nasdaq: OPXA) (“Opexa”) and Acer Therapeutics Inc. ... Investor Relations. Investors and ... Opexa Investor Contact: Neil K. Warma. Tel ...
People also ask
What does investor relations do?
What is the investor relations section?
What is an investor relations strategy?
What is IR in business?
Apr 16, 2024 · Investor Relations. Optex Systems, Inc. T: 972-764-5718. IR@optexsys.com. Transfer Agent. Equity ...
Missing: opxa | Show results with:opxa
Feb 7, 2013 · The 15th Annual BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.